Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

New report focusing on erectile dysfunction from female perspective published by Superdrug Online Doctor

Erectile dysfunction is a common condition that can affect men everywhere, in fact more than half of men aged 40-70 have been affected.

15 Feb 2016

High intensity focused ultrasound provides important treatment for men with prostate cancer

For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).

26 Jan 2016

Men not having important discussions with health providers about prostate cancer screening, treatment

Researchers at the University of Nebraska Medical Center and the University of Memphis recently published an article in the American Journal of Men's Health which found that men and their health providers are not having important discussions when it comes to prostate cancer screening and treatment.

7 Jan 2016

Penile prostheses benefit men with erectile dysfunction

Most men who receive penile prostheses are very satisfied with the implants, indicating that the intervention is a valid treatment for erectile dysfunction.

8 Dec 2015

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

27 Nov 2015

Health insurance coverage for transgender people is cost-effective, study finds

A new analysis led by the Johns Hopkins Bloomberg School of Public Health suggests that while most U.S. health insurance plans deny benefits to transgender men and women for medical care necessary to transition to the opposite sex, paying for sex reassignment surgery and hormones is actually cost-effective.

25 Nov 2015

Sildenafil drug improves insulin sensitivity in people at risk for diabetes

The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers at Vanderbilt University Medical Center reported today.

19 Nov 2015

Johns Hopkins researchers present new healthcare tips from American Heart Association Meeting

Linking digital activity trackers to smartphones and periodically pinging users with personalized texts that urge them to walk more can significantly increase physical activity levels and spark healthy behavior changes, according to findings of a pilot study conducted at Johns Hopkins.

13 Nov 2015

Expert proposes new solution to current gridlock over regulation of dietary supplements

A former principal deputy commissioner of the U.S. Food and Drug Administration is proposing a solution to the current gridlock over the regulation of dietary supplements: Focus less on whether these vitamins, minerals and herbal extracts actually do what they claim and instead take important steps to improve their safety.

3 Nov 2015

U-M study suggests new therapeutic strategy for treating Duchene muscular dystrophy

Every heart beat and step in our daily lives is dependent on the integrity of muscles and the proteins that keep them strong and free of injury as they contract and relax.

27 Oct 2015

Psychological interventions may improve sexual health of men with sleep apnea

Burdens related to poor sleep may put men with sleep apnea at increased risk of erectile dysfunction. In a study of 713 male patients who visited Seoul National University Hospital for snoring and/or daytime sleepiness from 2006 to 2014, depressive symptoms and a low quality of life due to sleep problems were clearly linked to erectile dysfunction.

20 Oct 2015

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.

12 Oct 2015

Sexual activity rarely causes heart attack

Sex is rarely the cause of a heart attack, and most heart disease patients are safe to resume sexual activity after a heart attack, according to a research letter published today in the Journal of the American College of Cardiology.

21 Sep 2015

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug development programs.

28 Aug 2015

Urologists report success in treating bladder issues, pelvic pain through neuromodulation technique

Millions of people suffer from bladder dysfunction, including about 30 million in the U.S. One in seven women experience chronic pelvic pain. These are not only health issues, but quality of life issues.

18 Aug 2015

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada.

12 Aug 2015

Increased radiation dose offers survival benefit for men with medium- and high-risk prostate cancer

Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, according to a new study from Penn Medicine published this week in JAMA Oncology. Already-high survival rates for men with low-risk prostate cancer were unaffected by higher radiation dosages compared to lower radiation dosages.

17 Jul 2015

New study evaluates impact of U.S. Preventive Services Task Force Guidelines for PSA screening

Current U.S. Preventive Services Task Force Guidelines for prostate screening may be impacting the detection of high-risk prostate cancer.

14 Jul 2015

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

The main symptoms of advanced prostate cancer can include (but are not limited to) difficulty walking or climbing steps, unexplained pain, troubled sleep and taking pain relievers daily.

From CancerCare 7 Jul 2015

Expectant management remains underused for men with low-risk prostate cancer

Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant management, is a useful approach for a large number of men with localized tumors and could spare them the debilitating side effects of aggressive treatments that are too often unnecessarily used in this patient population, a UCLA review of common practices in prostate cancer has found.

7 Jul 2015

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

New report focusing on erectile dysfunction from female perspective published by Superdrug Online Doctor

High intensity focused ultrasound provides important treatment for men with prostate cancer

Men not having important discussions with health providers about prostate cancer screening, treatment

Penile prostheses benefit men with erectile dysfunction

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Health insurance coverage for transgender people is cost-effective, study finds

Sildenafil drug improves insulin sensitivity in people at risk for diabetes

Johns Hopkins researchers present new healthcare tips from American Heart Association Meeting

Expert proposes new solution to current gridlock over regulation of dietary supplements

U-M study suggests new therapeutic strategy for treating Duchene muscular dystrophy

Psychological interventions may improve sexual health of men with sleep apnea

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Sexual activity rarely causes heart attack

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

Urologists report success in treating bladder issues, pelvic pain through neuromodulation technique

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Increased radiation dose offers survival benefit for men with medium- and high-risk prostate cancer

New study evaluates impact of U.S. Preventive Services Task Force Guidelines for PSA screening

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

Expectant management remains underused for men with low-risk prostate cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in